QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced an agreement with…
Super UserNovember 20, 2013
Paul Silber had some unexpected advice from a venture capitalist for the…
Super UserNovember 18, 2013
Much has been written about the pharmaceutical industry’s R&D-productivity challenge during the…
Super UserNovember 18, 2013
GlaxoSmithKline and Theravance's new inhaled lung drug Relvar has been approved in…
Super UserNovember 18, 2013
QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced an agreement with…
Super UserNovember 18, 2013
AstraZeneca (AZ) has strengthened its research team by appointing leading academic Dr…
Super UserNovember 18, 2013
A Cambridge company developing new drugs focused around DNA damage and genetically…
Super UserNovember 18, 2013